TRAIL is a promising anticancer therapeutic agent that is able to induce apoptosis in various tumour cells while leaving normal cells unharmed (Ashkenazi et al. 1999; Lawrence et al. 2001). The gene discussed is TNFSF10; the disease is neoplasm.